FdaApplication
NDA 020925
Identifiers
- fda_app_no: NDA020925
Properties
| Property | Value |
|---|---|
| applicant_name | HALEON US HOLDINGS LLC |
| application_type | NDA |
| approval_date | 1992-08-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TAVIST-1 | CLEMASTINE FUMARATE | 1.34MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
1 product